Miro1 Mediates the Neuroprotective Effects of Electroacupuncture Against Cerebral Ischemia-Reperfusion Injury in Mice.

Researchers investigated how electroacupuncture (EA) protects the brain after stroke in mice. Stroke causes brain cells to lose blood supply, and when blood flow returns, additional damage can occur—a condition called ischemia-reperfusion injury. This study focused on whether EA could help brain cells recover by improving their energy-producing structures called mitochondria. Scientists used 126 mice divided into seven groups, treating some with EA at the Baihui acupoint before inducing stroke-like conditions. They discovered that EA worked by increasing a protein called Miro1 in supporting brain cells called astrocytes. This protein appears to help transfer healthy mitochondria from astrocytes to damaged neurons, restoring their energy levels and survival. Mice receiving EA showed smaller stroke areas, better neurological function, and improved brain cell survival compared to untreated mice. When researchers blocked Miro1, EA lost its protective effects, confirming this protein's essential role. Interestingly, simply increasing Miro1 levels produced similar benefits to EA treatment. For stroke patients, this research helps explain how acupuncture may protect brain tissue and support recovery at the cellular level. The findings suggest EA could be a valuable complementary therapy for stroke, though human studies are needed to confirm these effects. The study also reinforces the importance of early intervention, as EA was administered before the stroke event in this model. If you're considering acupuncture for stroke recovery or prevention, consult with a licensed acupuncturist trained in neurological conditions.

This murine study (n=126 C57BL/6 mice across seven groups) investigated EA's neuroprotective mechanisms in middle cerebral artery occlusion (MCAO)-induced ischemia-reperfusion injury. EA pretreatment at GV20 significantly reduced infarct volume, improved neurological deficit scores, and enhanced neuronal survival (p<0.01 vs. MCAO controls). Mechanistically, EA upregulated astrocytic Miro1 protein expression, facilitating mitochondrial transfer to damaged neurons, evidenced by increased neuronal TOM40 expression and ATP levels with concurrent decreased astrocytic ATP/TOM40 (p<0.01). Astrocyte-specific Miro1 knockdown (AAV-GFAP-shMiro1) abolished EA's neuroprotective effects, while Miro1 overexpression mimicked EA benefits without additive effects. Clinical relevance: This study elucidates EA's mechanism through astrocyte-to-neuron mitochondrial transfer mediated by Miro1, supporting EA as a complementary intervention for cerebral ischemia. The findings suggest potential therapeutic windows for preconditioning protocols in stroke-prone patients, though translation to clinical practice requires human trials investigating optimal timing and treatment parameters.